SMid Cap Biotech Analyst Cheng holds a conference call with President & CEO Leonard on December 1 at 11 am hosted by JPMorgan.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NTLA:
- Intellia Therapeutics Announces Proposed Public Offering of Common Stock
- Intellia Therapeutics price target raised to $129 from $121 at Chardan
- Intellia presents new interim data from first-in-human study of NTLA-2002 in HAE
- Intellia Therapeutics Presents New Interim Data from First-in-Human Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the American College of Allergy, Asthma & Immunology 2022 Annual Scientific Meeting
- Sell these stocks now, proven algorithm says